Diversity Outreach Case Study: Active SLE Phase III

Phase III Active Systemic Lupus Erythematosus (SLE) study; Innovative Trials supported community outreach to increase awareness and access to clinical trials among diverse communities. Sites receiving diversity outreach visits saw a 63% increase in randomised patients.